Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
TRex Bio Files for Nasdaq IPO

TRex Bio Files for Nasdaq IPO

MT newswireMT newswire2026/10/05 14:06

10:06 AM EDT, 10/05/2026 (MT Newswires) -- TRex Bio has filed a preliminary prospectus for an initial public offering of about 8.3 million common shares expected to be priced between $14 and $16 apiece, according to a filing with the US Securities and Exchange Commission Monday. TRex Bio said Eli Lilly (LLY) has indicated an interest buying shares of the company during the IPO, and that Eli Lilly's stake will not exceed 19.9% when combined with the shares it already owns. Underwriters were granted an option for a period of 30 days to purchase up to 1.25 million additional shares, TRex Bio said. The clinical-stage biopharmaceutical company said it expects net proceeds of about $111.3 million, which will be used to advance the clinical development of TRB-061 and TRB-071 as well as for working capital and general corporate purposes. The company has applied to list its common stock on the Nasdaq Global Select Market under the symbol "TRXB," the filing showed.

10:06 AM EDT, 10/05/2026 (MT Newswires) -- TRex Bio has filed a preliminary prospectus for an initial public offering of about 8.3 million common shares expected to be priced between $14 and $16 apiece, according to a filing with the US Securities and Exchange Commission Monday. TRex Bio said Eli Lilly (LLY) has indicated an interest buying shares of the company during the IPO, and that Eli Lilly's stake will not exceed 19.9% when combined with the shares it already owns. Underwriters were granted an option for a period of 30 days to purchase up to 1.25 million additional shares, TRex Bio said. The clinical-stage biopharmaceutical company said it expects net proceeds of about $111.3 million, which will be used to advance the clinical development of TRB-061 and TRB-071 as well as for working capital and general corporate purposes. The company has applied to list its common stock on the Nasdaq Global Select Market under the symbol "TRXB," the filing showed.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Korean retail investors shift to the US in Q3: Sold over 5.5 trillion won of Korean stocks, purchased more than 10 trillion won of US stocks

In the third quarter, Korean retail investors made net purchases of US stocks worth approximately 10.15 trillion won, marking a complete reversal from the previous pattern in the first half of the year, when they made net purchases of nearly 100 trillion won in KOSPI stocks. In September alone, the sell-off amount reached as high as 14.2 trillion won. Analysts attribute this shift to a combination of factors: a sharp decline in KOSPI at high levels, the continued strength of the US stock market driven by AI themes, and the appreciation of the Korean won reducing currency exchange costs.

华尔街见闻•2026/10/11 06:51